• About
        • About Us

          Hexima is a clinical stage, anti-infectives focused biotechnology company engaged in the research and development of plant defensin peptides for applications as human therapeutics.

        • About Hexima

        • About Us
        • Leadership
        • News & Presentations
        • Contact Us

        • Contact Us
  • Technology
        • Technology

          Antifungal plant defensin technology platform.

        • Our Technology

        • Antifungal Plant Defensins
        •  

        • Literature
  • Products
        • Products

          Safe and effective application of the plant defensin technology to the treatment of human fungal disease.

        • Products

        • Pezadeftide
        • Medical Applications

        • Onychomycosis
        • KOL Interviews
  • News & Presentations
  • Investors
        • Investors

          Share price, ASX announcements and investor resources.

        • Investor Resources

        • Investor Centre
        • Corporate Governance
        • ASX Announcements
        • Blank

        • Annual & Interim Reports
        • Investor Services
  • About
        • About Us

          Hexima is a clinical stage, anti-infectives focused biotechnology company engaged in the research and development of plant defensin peptides for applications as human therapeutics.

        • About Hexima

        • About Us
        • Leadership
        • News & Presentations
        • Contact Us

        • Contact Us
  • Technology
        • Technology

          Antifungal plant defensin technology platform.

        • Our Technology

        • Antifungal Plant Defensins
        •  

        • Literature
  • Products
        • Products

          Safe and effective application of the plant defensin technology to the treatment of human fungal disease.

        • Products

        • Pezadeftide
        • Medical Applications

        • Onychomycosis
        • KOL Interviews
  • News & Presentations
  • Investors
        • Investors

          Share price, ASX announcements and investor resources.

        • Investor Resources

        • Investor Centre
        • Corporate Governance
        • ASX Announcements
        • Blank

        • Annual & Interim Reports
        • Investor Services

Corporate Governance

To view and download the key charters and policies associated with our corporate governance, please click on the links below:

Constitution (pdf)

Corporate Governance Statement (pdf)

Anti-Bribery Policy (pdf)

Audit and Risk Management Committee Charter (pdf)

Board Charter (pdf)

Code of Conduct (pdf)

Continuous Disclosure Policy (pdf)

Diversity Policy (pdf)

Long-Term Incentive Plan (LTIP) (pdf)

Privacy Policy (pdf)

Process for Evaluation of Performance (pdf)

Remuneration and Nomination Committee Charter (pdf)

Risk Management Policy (pdf)

Security Trading Policy (pdf)

Shareholder Communication Policy (pdf)

US Sub-Plan to LTIP (PDF)

Whistleblower Policy (pdf)

 

About Us

Hexima is a clinical stage, anti-infectives focused biotechnology company engaged in the research and development of plant defensin peptides for applications as human therapeutics.

  • Follow
  • Follow

Contact

Hexima Limited
Level 4, LIMS2
La Trobe University VIC 3086
Australia

Phone: +61 3 9479 1210

Stay up to date

For the latest shareholder information & investor news, subscribe to our email alerts.

Subscribe